{"transactions":[{"id":770170,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-20T09:03:22.000Z","date":"2026-05-18","kind":"purchase","planned":false,"acquired":true,"shares":7100,"price":4.789,"value":34001.9,"ownership":{"direct":true},"balance_after":7100,"source":{"system":"sec-edgar","filing":"0001683168-26-004145","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853985/000168316826004145/ownership.xml","form_type":"4"}},{"id":930627,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-27T21:30:21.000Z","date":"2026-01-26","kind":"grant","planned":false,"acquired":true,"shares":37313,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on January 26, 2027."}],"balance_after":176407,"source":{"system":"sec-edgar","filing":"0001493152-26-003805","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315226003805/ownership.xml","form_type":"4"}},{"id":993980,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2025-11-19T17:00:04.000Z","date":"2025-11-17","kind":"grant","planned":false,"acquired":true,"shares":1517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The option grant was approved by the compensation committee of CNS Pharmaceutical, Inc.'s board of directors on June 6, 2025, subject to shareholder approval of the stock option plan under which the option was granted. CNS Pharmaceutical, Inc.'s shareholders approved the plan at the company's annual meeting on November 17, 2025 (the \"Shareholder Approval Date\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Issued in connection with the reporting person's employment with the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options set forth in the table vest in four equal quarterly installments commencing on the Shareholder Approval Date, subject to the reporting person's continued employment on each vesting date."}],"balance_after":1517,"derivative":{"exercise_price":12.48,"expiration_date":"2035-11-17","underlying":"Common Stock","underlying_shares":1517},"source":{"system":"sec-edgar","filing":"0001683168-25-008563","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853985/000168316825008563/ownership.xml","form_type":"4"}},{"id":1089817,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-10T20:30:32.000Z","date":"2025-07-09","kind":"sale","planned":false,"acquired":false,"shares":10738,"price":5.8557,"value":62878.5066,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with the vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.78 to $5.92 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":139094,"source":{"system":"sec-edgar","filing":"0001641172-25-018602","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000164117225018602/ownership.xml","form_type":"4"}},{"id":1170295,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-17T20:05:08.000Z","date":"2025-04-16","kind":"grant","planned":false,"acquired":true,"shares":115194,"price":0.8681,"value":99999.9114,"ownership":{"direct":true},"balance_after":165238,"source":{"system":"sec-edgar","filing":"0001641172-25-005221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000164117225005221/ownership.xml","form_type":"4"}},{"id":1187143,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-02T01:04:48.000Z","date":"2025-03-30","kind":"grant","planned":false,"acquired":true,"shares":46629,"price":0.89,"value":41499.81,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares issued pursuant to the 2023 Stock Incentive Plan, in lieu of $41,500 accrued in cash retainers under the Issuer's Non-Employee Director Compensation Program."}],"balance_after":50044,"source":{"system":"sec-edgar","filing":"0001641172-25-002234","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000164117225002234/ownership.xml","form_type":"4"}},{"id":1288480,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-04T01:37:45.000Z","date":"2025-01-31","kind":"grant","planned":false,"acquired":true,"shares":36101,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Upon vesting, a portion of the restricted stock may be surrendered to satisfy the reporting person's tax withholding obligation. Any deemed disposition of the withheld shares would be exempt pursuant to Rule 16b-3(e)."},{"field":"shares","element":"transactionShares","label":"F2","text":"All of the restricted stock will vest on January 31, 2026."}],"balance_after":149832,"source":{"system":"sec-edgar","filing":"0001493152-25-004751","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315225004751/ownership.xml","form_type":"4"}},{"id":1324743,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-12-20T22:06:31.000Z","date":"2024-12-18","kind":"grant","planned":false,"acquired":true,"shares":420000,"price":0.071,"value":29820.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents options to purchase common stock, granted under the Issuer's 2023 Stock Incentive Plan, which were granted at the conclusion of the Issuer's 2024 annual meeting of stockholders."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options will vest on the earlier of (x) the first anniversary of the date of grant, or (y) the date immediately prior to the next annual meeting of the Issuer's stockholders following the date of grant."}],"balance_after":420000,"derivative":{"exercise_price":0.071,"expiration_date":"2034-12-18","underlying":"Common Stock","underlying_shares":420000},"source":{"system":"sec-edgar","filing":"0001493152-24-051097","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224051097/ownership.xml","form_type":"4"}},{"id":1357820,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-20T21:30:05.000Z","date":"2024-11-18","kind":"grant","planned":false,"acquired":true,"shares":266594,"price":0.0919,"value":24499.9886,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares issued in lieu of $24,500 accrued in cash retainers under the Issuer's Non-Employee Director Compensation Program."}],"balance_after":341594,"source":{"system":"sec-edgar","filing":"0001493152-24-046991","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224046991/ownership.xml","form_type":"4"}},{"id":1357819,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-11-20T21:30:05.000Z","date":"2024-11-18","kind":"grant","planned":false,"acquired":true,"shares":75000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares are fully vested and were granted under the Issuer's 2023 Stock Incentive Plan."}],"balance_after":75000,"source":{"system":"sec-edgar","filing":"0001493152-24-046991","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315224046991/ownership.xml","form_type":"4"}},{"id":1399519,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2024-09-25T16:53:10.000Z","date":"2024-09-23","kind":"grant","planned":false,"acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in accordance with the following schedule: (i) one-third of the shares subject to the option vest on January 1, 2025; (ii) one-third of the shares subject to the option vest on January 1, 2026; and (iii) one-third of the shares subject to the option vest on January 1, 2027."}],"balance_after":30000,"derivative":{"exercise_price":2.46,"expiration_date":"2034-09-23","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001104659-24-102833","document":"tm2424771d1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853985/000110465924102833/tm2424771d1_4seq1.xml","form_type":"4"}},{"id":1422646,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-08-27T23:08:23.000Z","date":"2024-08-26","kind":"grant","planned":false,"acquired":true,"shares":11797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The acquisition was exempt pursuant to Rule 16b-3(d)."},{"field":"shares","element":"transactionShares","label":"F2","text":"This stock grant represents the remainder of the 2024 annual grant to board of directors. This portion of the annual stock grant was withheld until all employees/management were allocated their shares and in order to enable onboarding of two new Board members. All of the restricted stock will vest on August 26, 2025."}],"balance_after":113731,"source":{"system":"sec-edgar","filing":"0001493152-24-034054","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224034054/ownership.xml","form_type":"4"}},{"id":1458006,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-09T20:35:34.000Z","date":"2024-07-08","kind":"grant","planned":false,"acquired":true,"shares":23611,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on July 8, 2025."}],"balance_after":101934,"source":{"system":"sec-edgar","filing":"0001493152-24-026641","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224026641/ownership.xml","form_type":"4"}},{"id":1534244,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-29T12:30:14.000Z","date":"2024-04-26","kind":"purchase","planned":false,"acquired":true,"shares":7550,"price":3.28,"value":24764.0,"ownership":{"direct":true},"balance_after":78323,"source":{"system":"sec-edgar","filing":"0001493152-24-016852","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315224016852/ownership.xml","form_type":"4"}},{"id":1543892,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2024-04-10T21:50:26.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":17500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit represents a contingent right to receive one share of the Company common stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The awards were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":64815,"derivative":{"underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001683168-24-002283","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1853985/000168316824002283/ownership.xml","form_type":"4"}},{"id":1543891,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2024-04-10T21:50:26.000Z","date":"2024-04-08","kind":"grant","planned":false,"acquired":true,"shares":17500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The awards were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The awards set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2025 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":47315,"derivative":{"exercise_price":0.2586,"expiration_date":"2034-04-08","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001683168-24-002283","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853985/000168316824002283/ownership.xml","form_type":"4"}},{"id":1722729,"issuer":{"id":1035,"kind":"organization","name":"CDT Equity Inc.","symbol":"CDT"},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-12-05T22:20:22.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":5.51,"value":358150.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents Options to purchase common stock, granted under the Company's 2023 Stock Incentive Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The stock options were granted with a ten-year term and vest 33.3% on each of the first three anniversaries of the vesting commencement date, which is September 22, 2023."}],"balance_after":65000,"derivative":{"exercise_price":5.51,"expiration_date":"2033-11-30","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001493152-23-043746","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1896212/000149315223043746/ownership.xml","form_type":"4"}},{"id":1761205,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-10-12T18:00:09.000Z","date":"2023-09-21","kind":"grant","planned":false,"acquired":true,"shares":26315,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":29815,"derivative":{"exercise_price":1.09,"expiration_date":"2033-09-22","underlying":"Common Stock","underlying_shares":26315},"source":{"system":"sec-edgar","filing":"0001683168-23-007107","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853985/000168316823007107/ownership.xml","form_type":"4/A","original_submission_date":"2023-09-25"}},{"id":1771879,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-09-29T20:30:19.000Z","date":"2023-09-27","kind":"sale","planned":false,"acquired":false,"shares":8330,"price":4.9128,"value":40923.624,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Weighted average price. These shares were sold in multiple transactions at prices ranging from $3.8200 to $4.2100 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":70773,"source":{"system":"sec-edgar","filing":"0001493152-23-034857","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223034857/ownership.xml","form_type":"4"}},{"id":1774021,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-09-25T18:20:56.000Z","date":"2023-09-21","kind":"grant","planned":false,"acquired":true,"shares":45974,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The stock options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options set forth in this table vest on the earlier of the one-year anniversary of the date of issuance or the date of the 2024 annual meeting, subject to the grantee's continued service to the Company on the vesting date."}],"balance_after":74914,"derivative":{"exercise_price":1.09,"expiration_date":"2033-09-22","underlying":"Common Stock","underlying_shares":49474},"source":{"system":"sec-edgar","filing":"0001683168-23-006678","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853985/000168316823006678/ownership.xml","form_type":"4"}},{"id":1836690,"issuer":{"id":8537,"kind":"organization","name":"AVENUE THERAPEUTICS, INC."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee stock option (right to buy)","published_at":"2023-07-05T16:10:00.000Z","date":"2023-06-30","kind":"grant","planned":false,"acquired":true,"shares":100000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in accordance with the following schedule: (i) one-third of the shares subject to the option vest on January 1, 2024; (ii) one-third of the shares subject to the option vest on January 1, 2025; and (iii) one-third of the shares subject to the option vest on January 1, 2026."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Effective September 22, 2022, the Issuer effected a one-for-fifteen reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split."}],"balance_after":100000,"derivative":{"exercise_price":1.14,"expiration_date":"2033-06-30","underlying":"Common Stock","underlying_shares":100000},"source":{"system":"sec-edgar","filing":"0001104659-23-078101","document":"tm2320488d6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853985/000110465923078101/tm2320488d6_4seq1.xml","form_type":"4"}},{"id":1853510,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:05:28.000Z","date":"2023-06-14","kind":"grant","planned":false,"acquired":true,"shares":58689,"price":4.62,"value":271143.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on June 14, 2024."}],"balance_after":79103,"source":{"system":"sec-edgar","filing":"0001493152-23-021650","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315223021650/ownership.xml","form_type":"4"}},{"id":2068439,"issuer":{"id":8048,"kind":"organization","name":"CNS Pharmaceuticals, Inc."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to purchase common stock","published_at":"2023-01-04T16:02:23.000Z","date":"2022-12-30","kind":"grant","acquired":true,"shares":3500,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The options were issued in connection with the reporting person's Board of Director services to the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options set forth in this table vest in 36 equal monthly installments succeeding the issuance date, or December 30, 2022, subject to the grantee's continued service on the Company's Board of Directors on each vesting date."}],"balance_after":3500,"derivative":{"exercise_price":2.4,"expiration_date":"2022-12-30","underlying":"Common Stock","underlying_shares":3500},"source":{"system":"sec-edgar","filing":"0001683168-23-000026","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1853985/000168316823000026/ownership.xml","form_type":"4"}},{"id":2150199,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-09-28T20:41:31.000Z","date":"2022-09-26","kind":"grant","acquired":true,"shares":13400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on September 26, 2023."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On July 1, 2022, the issuer effectuated a 1-for-25 reverse stock split."}],"balance_after":20414,"source":{"system":"sec-edgar","filing":"0001493152-22-027054","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315222027054/ownership.xml","form_type":"4"}},{"id":2694356,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-05-28T01:46:31.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":98168,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"All of the stock options will vest on November 25, 2021."}],"balance_after":98168,"derivative":{"exercise_price":1.49,"expiration_date":"2031-05-25","underlying":"Common Stock","underlying_shares":98168},"source":{"system":"sec-edgar","filing":"0001493152-21-013122","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221013122/ownership.xml","form_type":"4"}},{"id":2694355,"issuer":{"id":5808,"kind":"organization","name":"ABEONA THERAPEUTICS INC."},"owners":[{"id":45701,"kind":"person","name":"Charles Faith L.","position":1,"cik":"0001853985","reported_name":"Charles Faith L.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-05-28T01:46:31.000Z","date":"2021-05-25","kind":"grant","acquired":true,"shares":77181,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"All of the restricted stock will vest on November 25, 2021."}],"balance_after":77181,"source":{"system":"sec-edgar","filing":"0001493152-21-013122","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/318306/000149315221013122/ownership.xml","form_type":"4"}}]}